It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So we'll take a look at whether insiders have been buying or selling shares in Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI).
What Is Insider Buying?
It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market.
Insider transactions are not the most important thing when it comes to long-term investing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. For example, a Harvard University study found that 'insider purchases earn abnormal returns of more than 6% per year.
See our latest analysis for Brainstorm Cell Therapeutics
The Last 12 Months Of Insider Transactions At Brainstorm Cell Therapeutics
Over the last year, we can see that the biggest insider purchase was by insider Joseph Daly for US$1.6m worth of shares, at about US$3.66 per share. That implies that an insider found the current price of US$4.38 per share to be enticing. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. Happily, the Brainstorm Cell Therapeutics insiders decided to buy shares at close to current prices. We note that Joseph Daly was both the biggest buyer and the biggest seller.
Happily, we note that in the last year insiders paid US$1.7m for 467.00k shares. But insiders sold 22038 shares worth US$86k. In the last twelve months there was more buying than selling by Brainstorm Cell Therapeutics insiders. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Brainstorm Cell Therapeutics Insiders Bought Stock Recently
There has been significantly more insider buying, than selling, at Brainstorm Cell Therapeutics, over the last three months. In total, four insiders bought US$1.7m worth of shares in that time. But we did see insider Joseph Daly sell shares worth US$44k. Insiders have spent more buying shares than they have selling, so on balance we think they are are probably optimistic.
Does Brainstorm Cell Therapeutics Boast High Insider Ownership?
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 7.7% of Brainstorm Cell Therapeutics shares, worth about US$7.6m, according to our data. However, it's possible that insiders might have an indirect interest through a more complex structure. We do generally prefer see higher levels of insider ownership.
So What Do The Brainstorm Cell Therapeutics Insider Transactions Indicate?
It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. While the overall levels of insider ownership are below what we'd like to see, the history of transactions imply that Brainstorm Cell Therapeutics insiders are reasonably well aligned, and optimistic for the future. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.
"Many" - Google News
January 17, 2020 at 06:00PM
https://ift.tt/2sCkRlq
How Many Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shares Did Insiders Buy, In The Last Year? - Yahoo Finance
"Many" - Google News
https://ift.tt/2QsfYVa
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "How Many Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shares Did Insiders Buy, In The Last Year? - Yahoo Finance"
Post a Comment